Neuropeptide Y and its C-terminal fragments acting on Y2 receptor: Raman and SERS spectroscopy studies

被引:15
|
作者
Domin, Helena [1 ]
Pieta, Ewa [2 ]
Piergies, Natalia [2 ]
Swiech, Dominika [2 ]
Kim, Younkyoo [3 ]
Proniewicz, Leonard M. [2 ]
Proniewicz, Edyta [4 ]
机构
[1] Polish Acad Sci, Inst Pharmacol, Dept Neurobiol, PL-31343 Krakow, Poland
[2] Jagiellonian Univ, Fac Chem, PL-30060 Krakow, Poland
[3] Hankuk Univ Foreign Studies, Dept Chem, Yongin 449791, Kyunggi Do, South Korea
[4] AGH Univ Sci & Technol, Fac Foundry Engn, PL-30059 Krakow, Poland
关键词
Raman spectroscopy; RS; Surface-enhanced Raman Spectroscopy; SERS; Neuropeptide Y; NPY; Silver colloid; Y-2 receptor agonist; Native and mutated C-terminal NPY fragments; SILVER SURFACE SERS; PANCREATIC-POLYPEPTIDE; SECONDARY STRUCTURE; DFT CALCULATIONS; ADSORPTION MODE; AMINO-ACIDS; FT-RAMAN; S-S; ANALOGS; PROTEINS;
D O I
10.1016/j.jcis.2014.09.053
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
In this paper, we present spectroscopic studies of neuropeptide Y (NPY) and its native NPY3-36, NPY13-36, and NPY22-36 and mutated acetyl-(Leu(28,31))-NPY24-36 C-terminal fragments acting on Y-2 receptor. Since there is some evidence for the correlation between the SERS patterns and the receptor binding ability, we performed a detailed analysis for these compounds at the metal/water interface using Raman spectroscopy (RS) and surface-enhanced Raman spectroscopy (SERS) methods. Many studies have suggested that interactions of this kind are crucial for a variety of biomedical and biochemical phenomena. The identification of amino acids in these peptide sequences by SERS allowed us to determine which molecular fragments were responsible for the interaction with the silver nanoparticle surface. Our findings demonstrated that in all of the investigated compounds, the NPY32-36 C-terminal fragment (Thr(32)-Arg(33)-Gln(34)-Arg(36)-Tyr(36)NH(2)) was involved in the adsorption process onto metal substrate. The results of the present study suggest that the same molecular fragment interacts with the Y-2 receptor, what proved the usefulness of the SERS method in the study of these biologically active compounds. The search for analogs acting on Y-2 receptor may be important from the viewpoint of possible future clinical applications. (c) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:111 / 118
页数:8
相关论文
共 50 条
  • [41] The discovery and synthesis of JNJ 31020028, a small molecule antagonist of the Neuropeptide Y Y2 receptor
    Swanson, Devin M.
    Wong, Victoria D.
    Jablonowski, Jill A.
    Shah, Chandra
    Rudolph, Dale A.
    Dvorak, Curt A.
    Seierstad, Mark
    Dvorak, Lisa K.
    Morton, Kirsten
    Nepomuceno, Diane
    Atack, John R.
    Bonaventure, Pascal
    Lovenberg, Timothy W.
    Carruthers, Nicholas I.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (18) : 5552 - 5556
  • [42] Characterization of the Brain Penetrant Neuropeptide Y Y2 Receptor Antagonist SF-11
    Domin, Helena
    Piergies, Natalia
    Pieta, Ewa
    Wyska, Elzbieta
    Pochwat, Bartlomiej
    Wlaz, Piotr
    Smialowska, Maria
    Paluszkiewicz, Czeslawa
    Szewczyk, Bernadeta
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (08): : 3454 - 3463
  • [43] Selective role of neuropeptide Y receptor subtype Y2 in the control of gonadotropin secretion in the rat
    Pinilla, L.
    Fernandez-Fernandez, R.
    Roa, J.
    Castellano, J. M.
    Tena-Sempere, M.
    Aguilar, E.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 293 (05): : E1385 - E1392
  • [44] Structural basis for Y2 receptor-mediated neuropeptide Y and peptide YY signaling
    Kang, Hyunook
    Park, Chaehee
    Choi, Yeol Kyo
    Bae, Jungnam
    Kwon, Sohee
    Kim, Jinuk
    Choi, Chulwon
    Seok, Chaok
    Im, Wonpil
    Choi, Hee-Jung
    STRUCTURE, 2023, 31 (01) : 44 - +
  • [45] Synthesis of short analogs of neuropeptide Y specific for the Y2 receptor using the TASP concept
    Grouzmann, E
    Razaname, A
    Tuchscherer, G
    Martire, M
    Mutter, M
    PEPTIDES: FRONTIERS OF PEPTIDES SCIENCE, 1999, : 625 - 626
  • [46] The Neuropeptide Y Y2 Receptor Is Coexpressed with Nppb in Primary Afferent Neurons and Y2 Activation Reduces Histaminergic and IL-31-Itch
    Ma, Haisha
    Gao, Tianle
    Jakobsson, Jon E. T.
    Weman, Hannah M.
    Xu, Bo
    Larhammar, Dan
    Lagerstrom, Malin C.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2020, 372 (01): : 73 - 82
  • [47] Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety:: evidence from Y2 receptor knockout mice
    Redrobe, JP
    Dumont, Y
    Herzog, H
    Quirion, R
    BEHAVIOURAL BRAIN RESEARCH, 2003, 141 (02) : 251 - 255
  • [48] Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients
    Testa, Alessandra
    Mallamaci, Francesca
    Macri, Roberta
    Pisano, Anna
    Spoto, Belinda
    Malatino, Lorenzo S.
    Stancanelli, Benedetta
    Tripepi, Giovanni
    Benedetto, Francesco A.
    Zoccali, Carmine
    JOURNAL OF HYPERTENSION, 2010, 28 (08) : 1745 - 1751
  • [49] C-terminal motif of human neuropeptide Y4 receptor determines internalization and arrestin recruitment
    Wanka, Lizzy
    Babilon, Stefanie
    Burkert, Kerstin
    Moerl, Karin
    Gurevich, Vsevolod V.
    Beck-Sickinger, Annette G.
    CELLULAR SIGNALLING, 2017, 29 : 233 - 239
  • [50] Neuropeptide-Y induced feeding is independent of classical Y1 and Y2 receptor activation.
    OShea, D
    Morgan, D
    Neeran, K
    Edwards, M
    Turton, M
    Choi, SJ
    Heath, M
    Gunn, I
    Ghatei, M
    Bloom, SR
    DIABETES, 1996, 45 : 621 - 621